The only problem I see leading into a cap raise(hopefully a bit later in the year) is that the great consistent assays similar to what we have been seeing won't be enough to get the SP back to the 40-50c mark. The market wants more now.
Don't get me wrong, they are great results and building the story/resource...but we need something more at this stage to hold the SP up at those prices.
The previous run from 25c up to above 50c was purely based on the deep diamond cores and what appeared to be the next Kararri.
To see that SP excitement again we need to either start hitting some viable underground grades or tie down a big deal/JV with NST.
Other things such as stellar results from corridor 2, Solomon and branches will be great to see and we should see some positive movement...but will it be enough to get the market properly excited in the current climate? I hope so but I'm not banking on it at this stage.
All that being said, I'm tipping Andy to have something up his sleeve. It just feels like something big is not far away......C'mon AT, work your magic.
- Forums
- ASX - By Stock
- NXM
- NXM the next multi bagger
NXM the next multi bagger, page-2396
-
- There are more pages in this discussion • 954 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NXM (ASX) to my watchlist
|
|||||
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.34M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 97367 | 4.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.3¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 97367 | 0.042 |
1 | 24390 | 0.041 |
2 | 106724 | 0.039 |
5 | 566358 | 0.038 |
1 | 400000 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.043 | 10000 | 1 |
0.048 | 145000 | 2 |
0.050 | 50000 | 1 |
0.052 | 200000 | 1 |
0.053 | 33445 | 1 |
Last trade - 07.00am 16/07/2024 (20 minute delay) ? |
Featured News
NXM (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online